Comorbidity and its Impact on COVID-19 Positive Patients who Died in Malaysia

Background Battling the COVID-19 pandemic still is the main agenda of many countries in the world today. This study evaluated the association between comorbidities and its impact on COVID-19 mortality.  

Method The public data set of the COVID-19 patient who passed away in 2020 in Malaysia due to COVID-19 was obtained from the daily press statement by the Ministry of Health Malaysia (MOH).  

Results Incidence of gout was more prevalent among patients ≥65 years (n=14 (6.1%)) and significantly associated with mortality (p=0.011), whereas obesity (n=14 (5.8%); p=0.003) and asthma (n=11 (4.5%); p=0.040) were more prevalent and significantly associated with mortality among patients <65 years. Heart disease (p=0.013) and obesity (p=0.003) significantly affected mortality in gender-based comparison.  

Conclusion Conclusively, there is a high incidence of comorbidities hypertension and diabetes mellitus among COVID-19 patients who died in Malaysia in 2020, but there is a small proportion of deaths among patients without pre-existing comorbidities.   

[Disclaimer: Abstract text might vary slightly from what is displayed in the e-poster]